Literature DB >> 3247302

The stability and solubility of progabide and its related metabolic derivatives.

N F Farraj1, S S Davis, G D Parr, H N Stevens.   

Abstract

The stability-pH profile of the gamma-aminobutyric acid prodrug. Progabide, was found to be bell shaped, with maximum stability occurring at pH 6 to 7 with a t1/2 of 126 min. Of its metabolic derivatives, the deamidated product PGA degraded in a similar fashion to Progabide, whereas the hydrolytic degradation product SL79.182 was, a expected, a stable compound. Progabide behaved as a typical weak base, with its solubility increasing with a decrease in pH. SL79.182 behaved as a typical phenolic weak acid, with its solubility increasing with an increase in pH. Both compounds displayed low intrinsic solubilities of 14.5 x 10(-5) M for Progabide and 33.4 x 10(-6) M for SL79.182. An increase in temperature resulted in an increase in the solubility but a decrease in the stability of Progabide. The data obtained indicate that the gastric pH and gastric emptying rate will have a profound effect on the oral bioavailability of Progabide.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3247302     DOI: 10.1023/a:1015941729400

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  pH-solubility profiles or organic carboxylic acids and their salts.

Authors:  Z T Chowhan
Journal:  J Pharm Sci       Date:  1978-09       Impact factor: 3.534

2.  A reversed-phase high-performance liquid chromatography assay procedure for progabide and its related metabolic derivatives.

Authors:  N F Farraj; S S Davis; G D Parr; H N Stevens
Journal:  Pharm Res       Date:  1987-02       Impact factor: 4.200

Review 3.  Pharmacokinetics and temperature.

Authors:  B E Ballard
Journal:  J Pharm Sci       Date:  1974-09       Impact factor: 3.534

4.  Solubility and ionization characteristics of doxepin and desmethyldoxepin.

Authors:  K Embil; G Torosian
Journal:  J Pharm Sci       Date:  1982-02       Impact factor: 3.534

5.  New anticonvulsants: Schiff bases of gamma-aminobutyric acid and gamma-aminobutyramide.

Authors:  J P Kaplan; B M Raizon; M Desarmenien; P Feltz; P M Headley; P Worms; K G Lloyd; G Bartholini
Journal:  J Med Chem       Date:  1980-06       Impact factor: 7.446

  5 in total
  1 in total

1.  A reversed-phase high-performance liquid chromatography assay procedure for progabide and its related metabolic derivatives.

Authors:  N F Farraj; S S Davis; G D Parr; H N Stevens
Journal:  Pharm Res       Date:  1987-02       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.